Efficacy, safety, and NGS analysis of orelabrutinib combined with obinutuzumab in untreated marginal zone lymphoma
Shanhu Qian(First Affiliated Hospital of Wenzhou Medical University), Songfu Jiang(Wenzhou Medical University), Yu Zhang(Second Affiliated Hospital of Dalian Medical University), Honglan Qian(Wenzhou Medical University), Yongyong Ma(Wenzhou Medical University), Shujuan Zhou(Shanghai Medical College of Fudan University), Yifen Shi(First Affiliated Hospital of Wenzhou Medical University)
Cited by 0
Related Papers
Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
|BioMed Research International|2018|50
Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma
|Blood|2019|40
Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients
|Oncotarget|2017|29
Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen
|Transplantation and Cellular Therapy|2019|27